Skip to main
NGVT

Ingevity (NGVT) Stock Forecast & Price Target

Ingevity (NGVT) Analyst Ratings

Based on 2 analyst ratings
Hold
Strong Buy 0%
Buy 50%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Ingevity Corp demonstrates a positive outlook due to effective management execution aimed at enhancing its portfolio through strategic asset sales, which are expected to reduce earnings volatility. The focus on refining operations is anticipated to bolster the company's margin profile significantly. Furthermore, the strong performance of the Performance Chemicals segment, which generates the majority of revenue, underpins the financial stability and growth potential of the company.

Bears say

Ingevity Corp faces significant risks that contribute to a negative outlook, primarily related to the potential decline in global auto production, which could negatively impact the company’s earnings and valuation multiples. The company’s dependency on transitioning its customer base towards automotive focused applications adds an additional layer of uncertainty, especially if it cannot adapt effectively and timely. Furthermore, various operational risks, including patent expirations, tariff impacts on the Performance Materials segment, weather-related disruptions, and competitive pressures, further complicate its financial stability and outlook.

Ingevity (NGVT) has been analyzed by 2 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 50% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Ingevity and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Ingevity (NGVT) Forecast

Analysts have given Ingevity (NGVT) a Hold based on their latest research and market trends.

According to 2 analysts, Ingevity (NGVT) has a Hold consensus rating as of Feb 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $67.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $67.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Ingevity (NGVT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.